查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球眼植入物市场
市场调查报告书
商品编码
1169021

2022-2029 年全球眼植入物市场

Global Ocular Implant Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2022-2029)，眼球植入物的全球市场规模预计将以 6.8% 的复合年增长率增长。

眼部植入物是通过外科手术永久植入眼眶的医疗设备。 该装置用于在插入眼球后随时间输送药物。

市场动态

推动全球眼部植入物市场的主要因素是，由于青光眼、年龄相关性黄斑变性 (AMD) 和白内障等眼科疾病的发病率上升、技术进步和新产品的出现，对眼部植入物的需求不断增加。例如作为推出

提高认识的努力和新技术先进眼部植入物的兴起预计将推动市场增长。

眼科植入物市场受到技术进步、人口老龄化、研发投资激增、青光眼、白内障和 AMD 等眼科疾病增加以及新兴市场医疗基础设施改善的推动。通过改进使用的新产品。

眼部植入物用于药物输送和美容目的。 这些植入物的采用率正在上升，导致政府举措和资金的增加。 这些资金将用于生产眼部植入产品，如人工晶状体、角膜植入物和青光眼植入物。 由于患有这些呼吸系统疾病的患者数量不断增加，这些应用的市场正在全球范围内扩大。 此外，预计主要参与者提供的技术先进的产品也将在市场增长中发挥重要作用。

各种新产品的发布、研究以及对这些眼部植入物的认识的提高正在促进市场的增长。 例如，2022 年 8 月，植入镜片和输送系统的设计者和供应商 STAAR Surgical Company 宣布了其最新的植入柱 EVO Visian，这是一种经 FDA 批准的视力矫正镜片，用于矫正散光和近视。我们正在宣布一种新的植入柱 EVO Visian与演员兼歌手乔乔纳斯 (Joe Jonas) 合作，以提高人们对镜片的认识。

产品召回和与眼部植入物批准相关的严格法规预计会阻碍市场增长。

关于眼部植入物审批的严格规章制度是阻碍眼部植入物市场增长的主要因素。 由于必须满足的各种要求，这些植入物的总成本增加了。

市场召回也是製约市场增长的主要因素。 由于洩漏和并发症，已经有几次召回。 例如，2022 年 10 月，罗氏公司因製造相关问题召回了其植入物 Susvimo。 Susvimo 是一种经批准的植入物，可将雷珠单抗输送至湿性年龄相关性黄斑变性患者的眼睛。 输送装置的隔膜或密封件存在製造问题，无法防止药物洩漏。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID，眼部植入物市场遭受了巨大损失。 主要製造商已经启动了各种研究和临床试验。 世界各地正在发生各种举措、产品发布、合作和合併，推动了市场的增长。 例如，2020 年 7 月，植入镜片和输送系统的设计者和供应商 STAAR Surgical Company 获得了 EVO Viva/EVO Visian ICL 的 CE 标誌，这是一种用于矫正老花眼的新型创新植入式人工晶状体。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第4章市场动态

  • 市场影响因素
    • 司机
      • 加大力度提高对眼部植入物的认识
      • 不断进步的技术进步
    • 约束因素
      • 与眼部植入物相关的产品召回
    • 商机
    • 影响分析

第5章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 人工晶状体
    • 单焦点人工晶状体
    • 多焦点人工晶状体
    • 可调节人工晶状体
    • 復曲面人工晶状体
  • 青光眼植入物
  • 角膜植入物
  • 眼部假体
  • 眼眶植入物
  • 其他

第八章材料

  • 疏水丙烯酸
  • 硅胶
  • 聚甲基丙烯酸甲酯 (PMMA)

第9章应用

  • 给药
  • 青光眼手术
  • 年龄相关性黄斑变性
  • 眼科手术
  • 美容目的
  • 其他

第 10 章最终用户

  • 医院
  • 门诊手术中心
  • 眼科诊所
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第13章公司简介

  • 诺华公司
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • STAAR Surgical
  • Bausch & Lomb Incorporated.
  • Carl Zeiss
  • Ophtec BV
  • MORCHER GmbH
  • Genentech, Inc.
  • AbbVie Inc.

第14章 全球眼科植入物市场-DataM

简介目录
Product Code: DMMD1200

Market Overview

The global ocular implant market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 6.8% during the forecast period (2022-2029).

The ocular implant is a medical device that is surgically embedded inside the socket of the eye permanently. This device is used for delivering drugs after insertion into the eye for an extended time.

Market Dynamics

The major factors driving the global ocular implant market are the rising demand for ocular implants owing to increasing incidences of ophthalmic disorders such as glaucoma, age-related macular degeneration (AMD) and cataract, technological advancements and novel product launches.

The increasing awareness initiatives and rising novel technologically advanced ocular implants are expected to drive the market's growth.

The ocular implant market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The ocular implant is used for delivering drugs and aesthetic purposes. The adoption of these implants is increasing, leading to rising government initiatives and funds. These funds will help produce ocular implant products such as ocular lenses, corneal implants or glaucoma implants. The market for these applications is increasing worldwide due to the enhanced number of these respiratory disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives about these ocular implants contribute to the market's growth. For instance, in August 2022, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its new partnership with Joe Jonas, an actor and singer, to create awareness of its latest implantable Collamer lenses, EVO Visian, an FDA-approved lens for vision correction developed for astigmatism and myopia correction.

Product recalls and stringent regulations associated with the approval of ocular implants are expected to hamper the market's growth.

Strict rules and regulations for the approval of ocular implants is the major factor hindering the growth of the ocular implant market. Various requirements must be fulfilled, leading to an increase in the overall cost of these implants.

Market recalls are also a leading factor restraining the growth of the market. Several recalls are taking place due to leakage or complications. For instance, in October 2022, Roche recalled its implant Susvimo due to a manufacturing-related issue. Susvimo is an approved implant that delivers ranibizumab into the eye of people with wet age-related macular degeneration. The septum or seal of the delivery device has some manufacturing issues and cannot keep the medicine from leaking out.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The ocular implant market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2020, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its novel, innovative implantable Collamer lens, EVO Viva/ EVO Visian ICL, for presbyopia correction, received CE Mark.

Segment Analysis

The Intraocular lenses segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The intraocular lenses segment is the highest market holder in the global ocular implant market. The global ocular implant market is segmented based on product type as intraocular lenses, glaucoma implants, corneal implants, ocular prostheses, orbital implants and more. The intraocular lenses segment is the largest market shareholder due to its inherent advantages over other implants, increasing technological advancements and novel product launches.

Intraocular lenses are artificial lenses implanted into the eye for myopia or cataract treatment purposes. It replaces the natural lens of the eye removed during the surgery and restores distant or near vision. These lenses are of various types: accommodating, mono-focal, multifocal, and toric. One of the leading causes of blindness is cataracts which can be treated with the help of these implants through surgery.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in September 2022, Johnson and Johnson Vision, part of Johnson and Johnson Medtech and an eye health company, introduced their novel intraocular lens powered by InteliLight technology and TECNIS symphony OptiBlue intraocular lens for correcting presbyopia. This lens with depth of focus joins the hybrid lens, TECNIS synergy intraocular lens, for spectacle independence in the InteliLight portfolio. This corrects presbyopia in more patients. These deliver low-light performance and superior contrast in this intraocular lens category.

Geographical Analysis

North America holds the largest market share in the global ocular implant market.

North America dominates the global ocular implant market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of ocular implant applications in several ophthalmic conditions, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the ocular implant market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2020, Johnson & Johnson Vision, a company focusing on eye health, announced that its TECNIS Eyhance and TECNIS synergy intraocular lenses for cataract treatment got approved by Health Canada and will be available in the Canadian market.

Competitive Landscape

The ocular implant market is highly competitive with local and global companies' presence. Novartis Inc., Pfizer Inc., Johnson & Johnson Services, Inc., STAAR Surgical, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Genentech, Inc., AbbVie Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2022, Bausch + Lomb Corporation, an eye health company and Sanoculis, an ophthalmic device company, announced their strategic agreements developed to focus on glaucoma's unmet needs.

Novartis AG

Overview: Novartis is engaged in discovering, developing, manufacturing, and selling a wide range of pharmaceutical and generic medicines. The company has two operating divisions globally: Innovative medicines and Sandoz for biosimilars and generic pharmaceuticals.

Product Portfolio:

Clareon intraocular lens: This has an advanced, disposable and pre-loaded delivery system optic material. It can be implanted with a delivery system that is unique and automated.

Key Development: In June 2022, Novartis announced its acquisition of Kedalion Therapeutics along with its innovative AcuStream technology, a device that can provide accurate delivery with precise dosing of ophthalmic medications. This acquisition will expand the ophthalmic portfolio of Novartis.

The global ocular implant market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness initiatives for these ocular implants
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Product recalls associated with ocular implant
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Intraocular Lenses *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Monofocal IOLs
    • 7.2.4. MultifocalIOLs
    • 7.2.5. Accommodating IOLs
    • 7.2.6. Toric IOLs
  • 7.3. Glaucoma Implants
  • 7.4. Corneal Implants
  • 7.5. Ocular Prosthesis
  • 7.6. Orbital Implants
  • 7.7. Others

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Hydrophobic Acrylic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Silicone
  • 8.4. Polymethylmethacrylate (PMMA)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Drug Delivery *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Glaucoma Surgery
  • 9.4. Age-related Macular Degeneration
  • 9.5. Oculoplasty
  • 9.6. Aesthetic Purpose
  • 9.7. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye Specialty Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Novartis AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Pfizer Inc.
  • 13.3. Johnson & Johnson Services, Inc.
  • 13.4. STAAR Surgical
  • 13.5. Bausch & Lomb Incorporated.
  • 13.6. Carl Zeiss
  • 13.7. Ophtec BV
  • 13.8. MORCHER GmbH
  • 13.9. Genentech, Inc.
  • 13.10. AbbVie Inc.

LIST NOT EXHAUSTIVE

14. Global Ocular Implant Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us